Innovation1 Biotech Inc
Innovation1 Biotech Inc. focuses on researching, developing, producing, and selling pharmaceutical products. The company offers natural supplements for the treatment of symptoms associated with the flu and long covid under the NutraFlu and Nutravid19 brands; and other supplement and medical nutrition products. It also develops NLC001 that is in Phase II clinical trial for the treatment of long co… Read more
Market Cap & Net Worth: Innovation1 Biotech Inc (IVBT)
Innovation1 Biotech Inc (OTCQB:IVBT) has a market capitalization of $22.47K ($22.47K) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #46195 globally and #14425 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Innovation1 Biotech Inc's stock price $0.00 by its total outstanding shares 22470239 (22.47 Million).
Innovation1 Biotech Inc Market Cap History: 2017 to 2025
Innovation1 Biotech Inc's market capitalization history from 2017 to 2025. Data shows change from $25.84 Million to $22.47K (-58.82% CAGR).
Innovation1 Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Innovation1 Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
11016.25x
Innovation1 Biotech Inc's market cap is 11016.25 times its annual revenue
0.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
32.63x
Innovation1 Biotech Inc's market cap is 32.63 times its annual earnings
0.00x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $898.81K | $16.77K | -$975.52K | 53.59x | N/A |
| 2019 | $516.82K | $79.25K | -$170.07K | 6.52x | N/A |
| 2020 | $359.52K | $1.18K | -$2.58 Million | 304.42x | N/A |
| 2021 | $33.93 Million | $3.08K | $1.04 Million | 11016.25x | 32.63x |
Competitor Companies of IVBT by Market Capitalization
Companies near Innovation1 Biotech Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Innovation1 Biotech Inc by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Innovation1 Biotech Inc Historical Marketcap From 2017 to 2025
Between 2017 and today, Innovation1 Biotech Inc's market cap moved from $25.84 Million to $ 22.47K, with a yearly change of -58.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $22.47K | 0.00% |
| 2024 | $22.47K | -98.84% |
| 2023 | $1.93 Million | -9.47% |
| 2022 | $2.13 Million | -93.71% |
| 2021 | $33.93 Million | +9337.50% |
| 2020 | $359.52K | -30.43% |
| 2019 | $516.82K | -42.50% |
| 2018 | $898.81K | -96.52% |
| 2017 | $25.84 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Innovation1 Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.47K USD |
| MoneyControl | $22.47K USD |
| MarketWatch | $22.47K USD |
| marketcap.company | $22.47K USD |
| Reuters | $22.47K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.